PDT Partners’s Inspire Medical Systems INSP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-4,800
Closed -$443K 569
2025
Q4
$443K Buy
+4,800
New +$459K 0.03% 439
2025
Q2
Sell
-18,044
Closed -$2.87M 763
2025
Q1
$2.87M Buy
18,044
+2
+0% +$362 0.2% 173
2024
Q4
$3.34M Sell
18,042
-5,345
-23% -$1.04M 0.3% 111
2024
Q3
$4.94M Buy
+23,387
New +$4.06M 0.44% 30
2023
Q3
Sell
-3,098
Closed -$1.01M 633
2023
Q2
$1.01M Sell
3,098
-12,130
-80% -$3.47M 0.14% 248
2023
Q1
$3.56M Sell
15,228
-2,625
-15% -$664K 0.48% 41
2022
Q4
$4.5M Buy
17,853
+6,070
+52% +$1.29M 0.73% 2
2022
Q3
$2.09M Buy
11,783
+2,750
+30% +$553K 0.32% 60
2022
Q2
$1.65M Buy
9,033
+214
+2% +$42.7K 0.15% 221
2022
Q1
$2.26M Sell
8,819
-8,567
-49% -$1.96M 0.19% 143
2021
Q4
$4M Sell
17,386
-6,714
-28% -$1.64M 0.3% 92
2021
Q3
$5.61M Sell
24,100
-1,931
-7% -$403K 0.4% 37
2021
Q2
$5.03M Buy
26,031
+20,931
+410% +$4.15M 0.33% 69
2021
Q1
$1.06M Buy
5,100
+1,342
+36% +$285K 0.08% 363
2020
Q4
$707K Buy
+3,758
New +$614K 0.05% 389
2020
Q1
Sell
-5,186
Closed -$385K 752
2019
Q4
$385K Buy
+5,186
New +$333K 0.02% 485

Other funds holding INSP

PDT Partners's INSP Position: Q1 2026 in Review

PDT Partners sold out of Inspire Medical Systems (INSP) in Q1 2026, closing a stake of 4,800 shares — an estimated $443K sold.

PDT Partners first reported a position in INSP in Q4 2019 and held it in 16 quarters. The position peaked at $5.61M in Q3 2021. 301 funds tracked by Wall St. Rank hold INSP as of Q1 2026.

  • PDT Partners reported no remaining Inspire Medical Systems position as of Q1 2026 after selling out during the quarter.
  • PDT Partners sold 4,800 Inspire Medical Systems shares in Q1 2026, an estimated $443K.
  • PDT Partners first reported a position in Inspire Medical Systems in Q4 2019 and held it in 16 quarters.
  • PDT Partners's Inspire Medical Systems position peaked at $5.61M in Q3 2021.
  • 301 funds tracked by Wall St. Rank held Inspire Medical Systems as of Q1 2026.

Based on PDT Partners's 13F filing for Q1 2026, filed 15 May 2026.